Literature DB >> 24512598

Mesenchymal stem cells recruited by active TGFβ contribute to osteogenic vascular calcification.

Weishan Wang1, Changjun Li, Lijuan Pang, Chenhui Shi, Fengjing Guo, Anmin Chen, Xu Cao, Mei Wan.   

Abstract

Vascular calcification is an actively regulated process that culminates in organized extracellular matrix mineral deposition by osteoblast-like cells. The origins of the osteoblastic cells involved in this process and the underlying mechanisms remain to be defined. We previously revealed that active transforming growth factor (TGFβ) released from the injured arteries mobilizes mesenchymal stem cells (MSCs) to the blood stream and recruits the cells to the injured vessels for neointima formation. In this study, we used a low-density lipoprotein receptor (LDLR)-deficient mouse model (ldlr(-/-)), which develop progressive arterial calcification after having fed high-fat western diets (HFD), to examine whether TGFβ is involved in the mobilization of MSCs during vascular calcification. Nestin(+)/Sca1(+) cells were recruited to the diseased aorta at earlier time points, and osteocalcin(+) osteoblasts and the aortic calcification were seen at later time point in these mice. Importantly, we generated parabiotic pairs with shared blood circulation by crossing ldlr(-/-)mice fed HFD with transgenic mice, in which all the MSC-derived cells were fluorescently labeled. The labeled cells were detected not only in the peripheral blood but also in the arterial lesions in ldlr(-/-) mouse partners, and these blood circulation-originated cells gave rise to Ocn(+) osteoblastic cells at the arterial lesions. Both active TGFβ1 levels and MSCs in circulating blood were upregulated at the same time points when these cells appeared at the aortic tissue. Further, conditioned medium prepared by incubating the aortae from ldlr(-/-)mice fed HFD stimulated the migration of MSCs in the ex vivo transwell assays, and either TGFβ neutralizing antibody or the inhibitor of TGFβ Receptor I kinase (TβRI) antagonized this effect. Importantly, treatment of the mice with TβRI inhibitor blocked elevated blood MSC numbers and their recruitment to the arterial lesions. These findings suggest that TGFβ-recruited MSCs to the diseased vasculature contribute to the development of osteogenic vascular calcification.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24512598      PMCID: PMC4046215          DOI: 10.1089/scd.2013.0528

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  63 in total

1.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.

Authors:  Matt K Lee; Cécile Pardoux; Marie C Hall; Pierre S Lee; David Warburton; Jing Qing; Susan M Smith; Rik Derynck
Journal:  EMBO J       Date:  2007-08-02       Impact factor: 11.598

Review 2.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

Review 3.  SMADs: mediators and regulators of TGF-beta signaling.

Authors:  M Kretzschmar; J Massagué
Journal:  Curr Opin Genet Dev       Date:  1998-02       Impact factor: 5.578

4.  Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.

Authors:  H M Lazarus; S E Haynesworth; S L Gerson; A I Caplan
Journal:  J Hematother       Date:  1997-10

5.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.

Authors:  Motozo Yamashita; Karoly Fatyol; Chaoyang Jin; Xiangchun Wang; Zhenggang Liu; Ying E Zhang
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

Review 6.  TGF-beta-receptor-mediated signaling.

Authors:  R Derynck
Journal:  Trends Biochem Sci       Date:  1994-12       Impact factor: 13.807

7.  Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.

Authors:  Satoru Otsuru; Katsuto Tamai; Takehiko Yamazaki; Hideki Yoshikawa; Yasufumi Kaneda
Journal:  Stem Cells       Date:  2007-10-11       Impact factor: 6.277

8.  Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice.

Authors:  Kimie Tanaka; Masataka Sata; Takeshi Natori; Joo-Ri Kim-Kaneyama; Kiyoshi Nose; Motoko Shibanuma; Yasunobu Hirata; Ryozo Nagai
Journal:  FASEB J       Date:  2007-09-11       Impact factor: 5.191

9.  Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue.

Authors:  M H Barcellos-Hoff; E J Ehrhart; M Kalia; R Jirtle; K Flanders; M L Tsang
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

10.  Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo.

Authors:  D J Grainger; J C Metcalfe; A A Grace; D E Mosedale
Journal:  J Cell Sci       Date:  1998-10       Impact factor: 5.285

View more
  17 in total

1.  Menaquinone-4 modulates the expression levels of calcification-associated factors to inhibit calcification of rat aortic vascular smooth muscle cells in a dose-dependent manner.

Authors:  Liwen Cui; Jinsheng Xu; Junxia Zhang; Muqing Zhang; Shenglei Zhang; Yaling Bai
Journal:  Exp Ther Med       Date:  2018-07-27       Impact factor: 2.447

Review 2.  Arterial calcification: Finger-pointing at resident and circulating stem cells.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Gianandrea Pasquinelli
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

3.  Ras homolog family member A/Rho-associated protein kinase 1 signaling modulates lineage commitment of mesenchymal stem cells in asthmatic patients through lymphoid enhancer-binding factor 1.

Authors:  Xia Ke; Danh C Do; Changjun Li; Yilin Zhao; Marian Kollarik; Qingling Fu; Mei Wan; Peisong Gao
Journal:  J Allergy Clin Immunol       Date:  2018-09-05       Impact factor: 10.793

4.  MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation.

Authors:  Chang-Jun Li; Peng Cheng; Meng-Ke Liang; Yu-Si Chen; Qiong Lu; Jin-Yu Wang; Zhu-Ying Xia; Hou-De Zhou; Xu Cao; Hui Xie; Er-Yuan Liao; Xiang-Hang Luo
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

5.  Osteogenic changes in kidneys of hyperoxaluric rats.

Authors:  Sunil Joshi; William L Clapp; Wei Wang; Saeed R Khan
Journal:  Biochim Biophys Acta       Date:  2015-06-27

6.  Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease.

Authors:  Rafael Kramann; Claudia Goettsch; Janewit Wongboonsin; Hiroshi Iwata; Rebekka K Schneider; Christoph Kuppe; Nadine Kaesler; Monica Chang-Panesso; Flavia G Machado; Susannah Gratwohl; Kaushal Madhurima; Joshua D Hutcheson; Sanjay Jain; Elena Aikawa; Benjamin D Humphreys
Journal:  Cell Stem Cell       Date:  2016-09-08       Impact factor: 24.633

7.  Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis.

Authors:  Huan Jing; Li Liao; Yulin An; Xiaoxia Su; Shiyu Liu; Yi Shuai; Xinjing Zhang; Yan Jin
Journal:  Mol Ther       Date:  2015-08-26       Impact factor: 11.454

Review 8.  Multiple Pathways for Pathological Calcification in the Human Body.

Authors:  Netta Vidavsky; Jennie A M R Kunitake; Lara A Estroff
Journal:  Adv Healthc Mater       Date:  2020-12-04       Impact factor: 9.933

9.  PGC-1α Controls Skeletal Stem Cell Fate and Bone-Fat Balance in Osteoporosis and Skeletal Aging by Inducing TAZ.

Authors:  Bo Yu; Lihong Huo; Yunsong Liu; Peng Deng; John Szymanski; Jiong Li; Xianghang Luo; Christine Hong; Jiandie Lin; Cun-Yu Wang
Journal:  Cell Stem Cell       Date:  2018-07-12       Impact factor: 25.269

10.  RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix.

Authors:  Changjun Li; Gehua Zhen; Yu Chai; Liang Xie; Janet L Crane; Emily Farber; Charles R Farber; Xianghang Luo; Peisong Gao; Xu Cao; Mei Wan
Journal:  Nat Commun       Date:  2016-04-29       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.